Effectiveness of a pharmaceutical care program in the improvement of blood pressure monitoring in poorly controlled hypertensive patients. PressFarm Study;Efectividad de un programa de atención farmacéutica en la mejora del control de la presión arterial en pacientes hipertensos mal controlados. Estudio PressFarm

Hipertension y Riesgo Vascular

Volumn 27, Issue 1, 2010, Pages 13-22

  Torres, A ^a   Fite B ^a   Gascon P ^a   Barau, M ^a   Guayta Escolies, R ^a   Estrada Campmany, M ^a   Rodriguez C ^a  

^a Collegi de Farmacèutics de Barcelona ^*  (Spain)

Author keywords

Community pharmacy; Drug related problems; Hypertension; Non compliance; Pharmaceutical care

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; EARLY DIAGNOSIS; EXPERIMENTAL STUDY; FEMALE; HUMAN; HYPERTENSION; INTERVENTION STUDY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT GUIDANCE; PHARMACEUTICAL CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

EID: 73749087240     PISSN: 18891837     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hipert.2009.05.007     Document Type: Article

References (30)

1. Blackburn D.F., Dobson R.T., Blackburn J.L., and Wilson W. Cardiovascular morbidity associated with non-adherence to stain therapy. Pharmacotherapy 25 (2005) 1035-1043
2. Márquez E., Gil V., Martell N., De la Figuera M., Casado J.L., and Marín de Pablos J.L. Análisis de los estudios publicados sobre incumplimiento terapéutico en el tratamiento de la HTA en España entre los años 1984-2005. Atención Primaria 38 (2006) 325-332
3. Márquez E. Evaluación del incumplimiento en la práctica clínica. Hipertensión 25 (2008) 205-213
4. Wetzels G., Nelemans P., Schouten J., and Prins M. Facts and fictions of poor compliance as a cause of inadequate blood pressure control: A systematic review. J Hypertension 22 (2004) 1849-1855
5. Burnier M., Santschi V., and Favrat B. Monitoring compliance in resistant hypertension: An important step in patient management. J Hypertens 21 (2003) S37-S42
6. Williams G.H. Assessing patient wellness: New perspectives on quality of life and compliance. Am J Hypertens 11 (1998) 86-91
7. Helper C.D., and Strand l.M. Opportunities and responsabilities in pharmaceutical care. Am J Hosp Pharm 47 (1990) 533-543
8. Strand L.M., Cipolle R.J., Morley P.C., and Frakes M.J. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: Twenty-five years of experience. Curr Pharm Des 10 (2004) 3987-4001
9. Berenger B., La Casa C., and De la Matta M.J. Pharmaceutical care past, present and future. Curr Pharm Des 10 (2004) 3931-3946
10. Silveira de Castro M., Danni F., Costa M., Maximiliano P., Gus M., Beltrami L., et al. Pharmaceutical care program for patients with uncontrolled hypertension. Am J Hypertens 19 (2006) 528-533
11. Bunting B.A., Smith B.H., and Stherland S.E. The Asheville project: Clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipemia. J Am Pharm Assoc 48 (2008) 23-31
12. De Souza W.A., Yugar-Toledo J.C., Bergsten-Mendes G., Sabha M., and Moreno Jr. H. Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypeertension. Am J Syst Pharm 64 (2007) 1955-1961
13. Llibre Blanc per la integració de les activitats preventivas a l'oficina de farmàcia. Consell de Col·legis Farmacèutics de Catalunya i Departament de Sanitat i Seguretat Social. 1997. Barcelona: 1998.
14. Barau M. Protocols de serveis farmacèutics bàsics del programa d'atenció farmacèutica del COFB. Circ Farm 63 (2005) 39-41
15. Fité B. Els problemas relacionats amb el medicament i el programa d'atenció farmacèutica del COFB. Circ Farm 63 (2004) 39-41
16. Capdevila C., Doménech M., García E., Pastor E., Massot M., and Recasens E. Creació i validació d'una guia d'actuació farmacèutica per a la millora de l'observança terapèutica. Col{dot operator}legi de Farmacèutics de Barcelona. Barcelona: (2002)
17. McKenney J.M., Slinning J.M., and Henderson H.R. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 48 (1973) 1104-1111
18. Schapansky L.M. Pharmacisy's attitudes toward diabetes. J Am Pharm Assoc 43 (2000) 371-377
19. Lenz T.L. Therapeutic lifestyle changes and pharmaceutical care in the treatment of dylipidemias in adults. J Am Pharm Assoc 45 (2005) 492-501
20. Eriksen M.P., Green L.W., and Fultz F.G. Principles of changing health behaviour. Cancer 62 (1988) 1768-1775
21. Forster A.J., Murff H.J., Peterson J.F., Gandhi T.K., and Bates D.W. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 138 (2003) 161-167
22. Kripaiani S., Phillips C., Basaviah P., Williams M.V., Saint S.K., and Baker D.W. Deficits in information transfer from inpatient to outpatient physicians at hospital discharge: A systematic review. J Gen Intern Med 19 (2004) 135
23. Hermansen-Kobuinicky C.J., Wiederholt J.B., and Chewning B. Adverse effect monitoring: Opportunity for patient care and pharmacy practice. J Am Pharm Assoc 44 (2004) 75-86
24. Foster A.J., Clark H.D., and Menard A. Adverse events among medical patients after discharge from the hospital. CMAJ 170 (2004) 345-349
25. Al-Rashed S.A., Wright D.J., Roebuck N., Sunter W., and Chrystyn H. The value of impatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol 54 (2002) 657-664
26. Baena M.I., Fajardo P., Luque F., Marín R., and Arcos A. Problemas relacionados con los medicamentos en usuarios de un servicio de urgencias hospitalario: resultados de la validación de un cuestionario. Pharm Care Esp 3 (2001) 345-357
27. Tuneu L., García-Peláez M., López S., Serra G., Alba G., De Irala C., et al. Problemas relacionados con los medicamentos en pacientes que visitan un servicio de urgencias. Pharm Care Esp 2 (2000) 177-192
28. Dudas V., Bookwalter T., Kerr K.M., and Pantilat S.Z. The impact of follow-up telephone calls to patients after hospitalization. Am J Med 30 (2001) 33-40
29. Gandhi T.K., Burstin H.R., and Cook E.F. Drug complications in out patients. J Gen Intern Med 15 (2000) 149-154
30. Barner J.C. Pharmaceutical Care Certificate Program: Assessment of pharmacists's implementation into practice. J Am Pharm Assoc 39 (1999) 362-367